| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 19,988 | 20,141 | 19,960 | 20,609 | | Cost of Revenue | 3,350 | 3,450 | 4,281 | 4,385 | | | Gross Profit | 16,638 | 16,691 | 15,679 | 16,224 | | | Operating Expenses | | Research Development | 3,551 | 3,903 | 3,503 | 3,440 | | Selling General and Administrative | 11,224 | 11,801 | 14,633 | 12,020 | | Non Recurring | 17 | (91) | 46 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,846 | 1,078 | (2,503) | 764 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
| 562 | 423 | | Earnings Before Interest And Taxes | 2,114 | 1,078 | (1,941) | 1,187 | | Interest Expense | (5) | 5 |
-
|
-
| | Income Before Tax | 2,119 | 1,073 | (1,941) | 1,187 | | Income Tax Expense | 273 | 329 | 288 | 177 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,846 | 744 | (2,229) | 1,010 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,846 | 744 | (2,229) | 1,010 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,846 | $744 | ($2,229) | $1,010 |
|
0.51% Nasdaq 
Income Statement
